… risk of cardiovascular mortality and cardiovascular disease in adults with AKI. We noted that
AKI was associated with cardiovascular mortality and major cardiovascular events … events. …

… The RR of developing serious cardiovascular events among aspirin-indicated patients … for
aspirin not indicated patients was 1.89 (95% CI, 1.03-3.45), P = .04. Of note, no patient in the …

… -patient, multicenter, double-blind RCT, designed to determine the impact of anemia therapy
with darbepoetin alfa on mortality and nonfatal cardiovascular events in patients … is event-…

… -risk patients did not determine whether SSRIs are associated with a greater or lesser risk of
cardiovascular … , the lack of large trials in these patients, and a lack of adequate reporting of …

… of cardiovascular events and mortality in a cohort of high-risk treated hypertensive patients.
… Only those considered high-risk patients were included and from the 3573 patients selected …

… In case of discrepancies in the number of cardiovascular events between published reports
and FDA files, data from the FDA were used. Finally, we extracted all data for the risk of …

… , we selected patients who did not have a cardiovascular event … for excluding patients who
had a cardiovascular event during … pressure change on early events during the dose titration …

… of cardiovascular events, as compared with the incidence among patients assigned to
placebo, during a follow-up period of four to six years. Given the large number of events and the …

… patient cohort and additionally in very high risk diabetic patients defined as those with histories
of cardiac events… for the diabetic patients, data from the nondiabetic hypertensive patients …

… All four algorithms evaluated in this study can be used to calculate the 10-year risk of a CV
event. Predicted risk for a CV event in patients with a follow-up time <10 years were adjusted …